ArticleScientific reports2026
Deciphering the molecular networks of 3-methylcholanthrene-induced clear cell renal cell carcinoma through multi-omics integration.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ultrasound-Assisted Ternary Deep Eutectic Solvent Extraction of Total Flavonoids fromAntioxidants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Exposure to 3-Methylcholanthrene (3-MC) may be associated with the development and progression of clear cell renal cell carcinoma (ccRCC); however, its underlying molecular mechanisms remain unclear. We conducted differential expression analyses across multiple datasets to identify target genes linked to ccRCC. By integrating SHapley Additive exPlanations (SHAP) with machine learning algorithms, network toxicology and molecular docking, we investigated the binding interactions between 3-MC and these target proteins. A total of 99 genes were identified as potential targets involved in 3-MC-induced ccRCC pathogenesis. Four core genes (GPC3, PIK3C2G, PPARA, and TRPA1) were selected through machine learning approaches. SHAP analysis demonstrated the combined contribution of these genes to the model's predictive performance. GPC3, PIK3C2G, and PPARA were significantly downregulated, whereas TRPA1 was upregulated (P < 0.05). Survival analysis using data from The Cancer Genome Atlas (TCGA) revealed significant differences in patient survival based on the expression levels of these genes. Molecular dynamics simulations validated the structural stability of the interaction between 3-MC and PPARA. These findings suggest that 3-MC promotes ccRCC pathogenesis by targeting specific genes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.